These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10147288)

  • 21. ["Managed care in Germany--social rights and economic aspects of possible adoption"].
    Pilgrim S; Pilgrim TB
    Gesundheitswesen; 1999 Oct; 61(10):487-8. PubMed ID: 10593053
    [No Abstract]   [Full Text] [Related]  

  • 22. The future of clinical social work and managed cost organizations.
    Munson CE
    Psychiatr Serv; 1997 Apr; 48(4):479-82. PubMed ID: 9090730
    [No Abstract]   [Full Text] [Related]  

  • 23. The challenge of rising health care costs--a view from the Congressional Budget Office.
    Orszag PR; Ellis P
    N Engl J Med; 2007 Nov; 357(18):1793-5. PubMed ID: 17978287
    [No Abstract]   [Full Text] [Related]  

  • 24. Healthcare reform: what is the impact on echo labs?
    J Am Soc Echocardiogr; 2010 Dec; 23(12):25A. PubMed ID: 21111921
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of managed care on prescription drug costs and benefits.
    Lyles A; Palumbo FB
    Pharmacoeconomics; 1999 Feb; 15(2):129-40. PubMed ID: 10351187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing the economic value of avoiding hospital admissions by shifting the management of gram+ acute bacterial skin and skin-structure infections to an outpatient care setting.
    Ektare V; Khachatryan A; Xue M; Dunne M; Johnson K; Stephens J
    J Med Econ; 2015; 18(12):1092-101. PubMed ID: 26368787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness issues for home i.v. therapy in the United States.
    Allen R
    Hosp Formul; 1993 Jan; 28 Suppl 1():37-40. PubMed ID: 10123837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Big Dog, Big Do-Do.
    Reed MK
    Minn Med; 2009 Nov; 92(11):34. PubMed ID: 20069995
    [No Abstract]   [Full Text] [Related]  

  • 29. MD/DO jobs and incomes may shrink. But there's good news: CLIA office lab regs may go!
    Griffin GC
    Postgrad Med; 1995 May; 97(5):13-4, 16. PubMed ID: 7753738
    [No Abstract]   [Full Text] [Related]  

  • 30. The neurosurgical intensive care unit in an era of health care reform.
    Johnson S; Nenov VI; Martin NA; Becker DP
    Neurosurg Clin N Am; 1994 Oct; 5(4):829-35. PubMed ID: 7827487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness and pricing of antibacterial drugs.
    Verhoef TI; Morris S
    Chem Biol Drug Des; 2015 Jan; 85(1):4-13. PubMed ID: 25521641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparing for what's ahead.
    Pallarito K; Greene J; Lutz S; Kenkel PJ; Morrissey J; Burns J; de Lafuente D; Scott L; Burda D; Japsen B
    Mod Healthc; 1994 Jan; 24(1):31-8, 40-4, 46-8. PubMed ID: 10130658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nursing and labor cost reduction.
    Walleck CA
    New Horiz; 1994 Aug; 2(3):291-5. PubMed ID: 8087586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A guideline for the use of pharmacoeconomic models of diabetes treatment in the US managed-care environment.
    Veenstra DL; Ramsey SD; Sullivan SD
    Pharmacoeconomics; 2002; 20 Suppl 1():21-30. PubMed ID: 12036381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cost-effectiveness of isotretinoin in the treatment of acne. Part 3. A cost-minimisation pharmaco-economic model.
    Wessels F; Anderson AN; Kropman K
    S Afr Med J; 1999 Jul; 89(7 Pt 2):791-4. PubMed ID: 10470319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Restructuring the health care delivery system in the United States.
    Taylor R; Lessin L
    J Health Care Finance; 1996; 22(4):33-60. PubMed ID: 8827484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Financial impact of a home intravenous antibiotic program on a medicare managed care program.
    Dalovisio JR; Juneau J; Baumgarten K; Kateiva J
    Clin Infect Dis; 2000 Apr; 30(4):639-42. PubMed ID: 10770722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacoeconomic series: Part 3. Applying pharmacoeconomic and quality-of-life measures to the formulary management process.
    Skaer TL
    Hosp Formul; 1993 Jun; 28(6):577-84. PubMed ID: 10126586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Universal Health Insurance Coverage in Massachusetts Did Not Change the Trajectory of Arthroplasty Use or Costs.
    Kurtz SM; Lau E; Ong KL; Katz JN; Bozic KJ
    Clin Orthop Relat Res; 2016 May; 474(5):1090-8. PubMed ID: 26683036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opportunities and challenges for measuring cost, quality, and clinical effectiveness in health care.
    Fishman PA; Hornbrook MC; Meenan RT; Goodman MJ
    Med Care Res Rev; 2004 Sep; 61(3 Suppl):124S-43S. PubMed ID: 15375288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.